Cibus (NASDAQ:CBUS) Given Buy Rating at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Cibus (NASDAQ:CBUS) in a research note issued to investors on Monday morning,Benzinga reports. HC Wainwright currently has a $25.00 target price on the stock.

CBUS has been the subject of several other research reports. Canaccord Genuity Group raised Cibus to a “strong-buy” rating in a research note on Friday, July 19th. Canaccord Genuity Group reaffirmed a “buy” rating and set a $20.00 target price on shares of Cibus in a research note on Tuesday, October 22nd. Finally, Alliance Global Partners decreased their target price on Cibus from $25.00 to $23.50 and set a “buy” rating for the company in a research note on Tuesday, September 24th.

Cibus Trading Up 9.0 %

Cibus stock opened at $5.75 on Monday. The stock has a 50-day moving average price of $4.08 and a two-hundred day moving average price of $8.75. Cibus has a 12 month low of $2.86 and a 12 month high of $23.18.

Institutional Trading of Cibus

A number of large investors have recently bought and sold shares of CBUS. SG Americas Securities LLC purchased a new stake in Cibus in the third quarter worth $33,000. FineMark National Bank & Trust grew its position in shares of Cibus by 24.3% in the second quarter. FineMark National Bank & Trust now owns 20,488 shares of the company’s stock valued at $202,000 after purchasing an additional 4,000 shares in the last quarter. Squarepoint Ops LLC purchased a new position in shares of Cibus in the second quarter valued at $214,000. Rhumbline Advisers purchased a new position in shares of Cibus in the second quarter valued at $221,000. Finally, Old West Investment Management LLC grew its position in shares of Cibus by 3.6% in the second quarter. Old West Investment Management LLC now owns 53,247 shares of the company’s stock valued at $524,000 after purchasing an additional 1,868 shares in the last quarter. 33.81% of the stock is owned by hedge funds and other institutional investors.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.